Unlike larger, widely covered names, NAII carries no reliable sell-side price targets. Yahoo Finance lists no one-year target estimate, Benzinga reports no consensus figure, and MarketBeat shows a consensus target of "N/A." The only published "rating" is a Weiss Ratings letter grade, currently a Sell, which does not attach a dollar price target. A handful of aggregator sites circulate widely inconsistent figures, including obvious data-entry errors, so no trustworthy analyst aggregate exists.
Because of this, the $1.50 objective is a fallback target grounded in public and technical discussion rather than analyst forecasts. The stock has collapsed from a 52-week high of $4.96 to near $0.94, and its 50-day moving average now sits at roughly $1.48. A move back to the round $1.50 area — essentially reclaiming that moving average — is the realistic mean-reversion milestone most frequently discussed for the shares. It is a technical recovery level, not a published analyst price target. I checked this setup against broader peer data using Tickeron’s AI Screener to confirm the relative positioning.
The shares have been trading near $1.00, with a market capitalization of roughly $6 million and a 52-week range of $0.94 to $4.96. Reaching $1.50 would require a gain of about 50% from the $1.00 level — a very large move for any equity, and an especially demanding one for a loss-making micro-cap in a persistent downtrend.
A credible path toward $1.50 would likely require two things to align. Fundamentally, the company would need to demonstrate a return toward profitability and margin repair. Technically, the stock would first need to hold the $1.00 psychological level and the $0.94 low, then reclaim the $1.50 zone that now acts as resistance.
Several factors could support a recovery. First, the valuation is depressed: the shares trade at roughly 0.12 times book value, well below the company's net asset base. Second, Chairman and CEO Mark A. LeDoux bought shares in early 2026 at prices between roughly $2.66 and $2.85, signaling insider confidence at levels far above the current quote. Third, management is restructuring — consolidating U.S. manufacturing into its Vista, California facility and planning to sell the underutilized Carlsbad site to add liquidity and reduce debt. Fourth, revenue is growing, with fiscal 2026 net sales up about 10% to $142.5 million, and the company has initiated a strategic-alternatives review that could surface value.
The obstacles are significant. NAII posted a fiscal fourth-quarter 2026 net loss of $13.5 million, including a $10.4 million non-cash impairment tied to the Carlsbad facility, and management guided to a full-year net loss. Gross margin contracted to 5% from 10.4% year over year amid factory underutilization. Cash and equivalents fell to $7.4 million as of June 30, 2026, from $12.3 million a year earlier. The business is also highly concentrated: private-label contract manufacturing accounted for roughly 94.5% of fiscal 2026 revenue, with a portion dependent on a single large customer. With no near-term path to profitability signaled, valuation alone may not be enough to reverse the downtrend.
The chart shows a prolonged decline, with the stock down sharply over one, three, and five years and trading below both its 50-day (about $1.48) and 200-day (about $2.34) moving averages. The 52-week low near $0.94 and the $1.00 round number form the immediate support zone. The first meaningful resistance is the $1.50 area — the round level and the 50-day average — followed by the 200-day average near $2.34. A sustained close below $0.94 would signal further downside rather than a recovery.
Analyst price targets typically reflect a roughly 12-month research horizon, but since no credible analyst targets exist here, the $1.50 level carries no fixed timeframe. Investors should watch the next quarterly report (the fiscal first quarter of 2027, expected around late November 2026), progress on the Carlsbad facility sale and strategic review, gross-margin trends, cash balances, and any further insider activity. Revenue growth that fails to translate into earnings would limit any sustained re-rating. From what I see, tracking these metrics closely will be essential.
The question of whether NAII can reach $1.50 is ultimately a question of whether a deeply discounted, loss-making contract manufacturer can begin repairing margins and rebuilding investor confidence. The target is a technical mean-reversion level tied to the 50-day moving average, not an analyst consensus, and it implies a very large roughly 50% move from current levels. Insider buying, a sub-book valuation, and restructuring efforts offer a plausible foundation, but persistent losses, margin compression, impairment charges, and customer concentration weigh heavily against the stock. Investors should monitor earnings, the asset-sale and strategic-review process, and whether the shares can hold above the $0.94 low before drawing conclusions.
In my own process, Tickeron's AI Daily Buy/Sell Signals have become a practical way to monitor momentum shifts in volatile names like this one. The platform applies AI-driven analysis to thousands of stocks and ETFs, helping identify trend changes that might otherwise require extensive manual review. It has added efficiency when following developments in micro-caps where liquidity and news flow can move quickly.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NAII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 40 of 45 cases where NAII's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.
The RSI Indicator entered the oversold zone -- be on the watch for NAII's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 73 cases where NAII's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for NAII just turned positive on October 20, 2026. Looking at past instances where NAII's MACD turned positive, the stock continued to rise in 31 of 47 cases over the following month. The odds of a continued upward trend are 66%.
Following a +5.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where NAII advanced for three days, in 123 of 185 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NAII as a result. In 87 of 109 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAII declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for NAII entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.139) is normal, around the industry mean (6.914). P/E Ratio (-0.324) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.083) is also within normal values, averaging (5.003).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. NAII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of customized nutritional supplements
Industry FoodMajorDiversified